Wang Yang's Form 4 filing
Yubo International Biotech Ltd (YBGJ) · filed Jun 2, 2025
- Accession no.
- 0001640334-25-000959
- Filed
- Jun 2, 2025, 2:19 PM ET
- Trade date
- Jul 15, 2024
- Filing delay
- 322 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $240.0K. It was filed 322 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wang YangCIK 0001830179 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | Class A Common Stock | SSaleDisposed | −2,000,000 | $0.12 | −$240,000 | 17,211,400 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.